Trial Outcomes & Findings for Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants (NCT NCT03156465)
NCT ID: NCT03156465
Last Updated: 2025-01-08
Results Overview
Parent questionnaire that consists of ten questions regarding a young infant or toddler's auditory behavior, e.g. "Does the child spontaneously respond to his/her name in quiet with auditory cues?" Each question is scored on a five point scale: 0=never, 1=rarely, 2=occasionally, 3=frequently, and 4=always. The aim of this tool is to assess the benefit of the child's personal amplification device(s). This questionnaire is generally used during the cochlear implant work-up to assess hearing aid benefit. It is also used post-cochlear implantation to chart the progress the child is making with his/her cochlear implant when other formalized speech perception tests are not appropriate.
COMPLETED
NA
11 participants
Preoperative through 24 months
2025-01-08
Participant Flow
Participant milestones
| Measure |
Hybrid L24 and Standard CI
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
|
|---|---|
|
Overall Study
STARTED
|
11
|
|
Overall Study
COMPLETED
|
9
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
Hybrid L24 and Standard CI
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
Baseline Characteristics
Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants
Baseline characteristics by cohort
| Measure |
Hybrid L24 and Standard CI
n=11 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
|
|---|---|
|
Age, Categorical
<=18 years
|
11 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
11 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
11 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Preoperative through 24 monthsPopulation: some children did not complete the visit
Parent questionnaire that consists of ten questions regarding a young infant or toddler's auditory behavior, e.g. "Does the child spontaneously respond to his/her name in quiet with auditory cues?" Each question is scored on a five point scale: 0=never, 1=rarely, 2=occasionally, 3=frequently, and 4=always. The aim of this tool is to assess the benefit of the child's personal amplification device(s). This questionnaire is generally used during the cochlear implant work-up to assess hearing aid benefit. It is also used post-cochlear implantation to chart the progress the child is making with his/her cochlear implant when other formalized speech perception tests are not appropriate.
Outcome measures
| Measure |
Hybrid L24 and Standard CI
n=9 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
|
|---|---|
|
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
Preoperative
|
0 percentage out of 40
Standard Error 0
|
|
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
3 months postoperative
|
53 percentage out of 40
Standard Error .07
|
|
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
6 months postoperative
|
64 percentage out of 40
Standard Error .07
|
|
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
12 months postoperative
|
75 percentage out of 40
Standard Error .03
|
|
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
24 months postoperative
|
83 percentage out of 40
Standard Error .05
|
PRIMARY outcome
Timeframe: 48 monthsPopulation: one child did not complete this test. Average age that the children reached a ceiling effect occurred at 30 months (SE: 3.19)
Speech perception test that requires the identification of a spondee or monosyllable from a set of four spondees (i.e., French fry, airplane, hotdog, popcorn) or monosyllables (i.e., ball, book, bird, boat), respectively presented in quiet. The CID test will be scored as total number of words correct. It will be administered in both the unilateral and bilateral listening conditions at 70 dB C. This test is given post-operatively until the child scores a ceiling effect which is considered 90% or better in all test conditions.
Outcome measures
| Measure |
Hybrid L24 and Standard CI
n=8 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
|
|---|---|
|
The Early Speech Perception Four Choice Spondee and Monosyllable
Left Ear
|
98 percentage of words correct
Standard Error .73
|
|
The Early Speech Perception Four Choice Spondee and Monosyllable
Right Ear
|
98 percentage of words correct
Standard Error 1.71
|
|
The Early Speech Perception Four Choice Spondee and Monosyllable
Bilateral
|
97 percentage of words correct
Standard Error 2.11
|
PRIMARY outcome
Timeframe: 60 monthsPopulation: one child withdrew before testing was completed. Average age of testing was 61 mos. (SE: 2.65)
The PB-K test has multiple 50-word lists. The test will be scored as total number of words correct as well as phonemically. It will be administered in both the unilateral and bilateral listening conditions at 70 dB C. Test is administered age-appropriately through study completion.
Outcome measures
| Measure |
Hybrid L24 and Standard CI
n=8 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
|
|---|---|
|
Phonetically Balanced-Kindergarten
Right Ear
|
80 percentage of words correct
Standard Error 3.5
|
|
Phonetically Balanced-Kindergarten
Left Ear
|
78 percentage of words correct
Standard Error 4.5
|
|
Phonetically Balanced-Kindergarten
Bilateral
|
81 percentage of words correct
Standard Error 5.6
|
Adverse Events
Hybrid L24 and Standard CI
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place